Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 5, 2007, Pages 1557-1566

  Kozak, Kevin R ^a   Kachnic, Lisa A ^a,b   Adams, Judith ^a   Crowley, Elizabeth M ^a   Alexander, Brian M ^a   Mamon, Harvey J ^c   Fernandez Del Castillo, Carlos ^a   Ryan, David P ^a   DeLaney, Thomas F ^a   Hong, Theodore S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dosimetric comparison; IMRT; Neoadjuvant therapy; Pancreatic cancer; Protons

Indexed keywords

DISEASES; DOSIMETRY; HEALTH CARE; RADIOTHERAPY; TISSUE ENGINEERING; TUMORS;

DOSIMETRIC COMPARISON; IMRT; NEOADJUVANT THERAPY; PANCREATIC CANCER;

ONCOLOGY;

CAPECITABINE; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DUODENUM; FEMALE; GENERAL HOSPITAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LIVER; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SMALL INTESTINE; STOMACH; TREATMENT PLANNING; UNITED STATES;

ADENOCARCINOMA; AGED; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; INTESTINE, SMALL; KIDNEY; LIVER; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PROTONS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; STOMACH; TUMOR BURDEN;

EID: 34547407250     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.056     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Willett C.G., Czito B.G., Bendell J.C., et al. Locally advanced pancreatic cancer. J Clin Oncol 23 (2005) 4538-4544
3. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trail of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782
4. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. New Engl J Med 350 (2004) 1200-1210
5. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
6. Hoffman J.P., Cooper H.S., Young N.A., et al. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater. J Hepatobiliary Pancreat Surg 5 (1998) 251-254
7. Hoffman J.P., Weese J.L., Solin L.J., et al. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 169 (1995) 71-78
8. Ishikawa O., Ohigashi H., Imaka S., et al. Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreatoduodenectomy. Arch Surg 126 (1991) 885-889
9. Ishikawa O., Ohigashi H., Imaka S., et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?. Arch Surg 129 (1994) 1075-1080
10. Whittington R., Solin L., Mohiuddin M., et al. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 54 (1984) 1991-1998
11. Willett C.G., Lewandrowski K., Warshaw A.L., et al. Resection margins in carcinoma of the head of the pancreas. Ann Surg 217 (1993) 144-148
12. Jessup J.M., Steele G., Mayer R.J., et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128 (1993) 559-564
13. White R., Lee C., Anscher M., et al. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6 (1999) 38-45
14. Kim H.J., Czischke K., Brennan M.F., et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg 6 (2002) 763-769
15. Ammori J.B., Colletti L.M., Zalupski M.M., et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 7 (2003) 766-772
16. The Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59 (1987) 2006-2010
17. Shoup M., Winston C., Brennen M., et al. Is there a role for staging laparotomy in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Surg 8 (2004) 1068-1071
18. Paganetti H., Niemierko A., Ancukiewicz M., et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53 (2002) 407-421
19. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
20. Cassady J.R. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 31 (1995) 1249-1256
21. Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 56 (1985) 2563-2568
22. Roldan G.E., Gunderson L.L., Nagorney D.M., et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61 (1988) 1110-1116
23. Ben-Josef E., Shields A.F., Vaishampayan U., et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59 (2004) 454-459
24. Milano M.T., Chmura S.J., Garofalo M.C., et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 59 (2004) 445-453
25. Bai Y.-R., Wu G.-H., Guo W.-J., et al. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: Results of a feasibility study. World J Gastroenterol 9 (2003) 2561-2564
26. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 176-183
27. Tho L.M., Glegg M., Paterson J., et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66 (2006) 505-513
28. Ito Y., Okusaka T., Kagami Y., et al. Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer. Anticancer Res 26 (2006) 3755-3759
29. Koong A.C., Le Q.T., Ho A., et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1017-1021
30. Koong A.C., Christofferson E., Le Q.T., et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63 (2005) 320-323
31. Hoyer M., Roed H., Sengelov L., et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 76 (2005) 48-53
32. Crane C.H., Ellis L.M., Abbruzzese J.L., et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24 (2006) 1145-1151
33. Zurlo A., Lomax A., Hoess A., et al. The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 48 (2000) 277-288
34. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 345 (2001) 638-646
35. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004) 15-24
36. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. New Engl J Med 336 (1997) 980-987
37. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
38. Spitz F.R., Abbruzzese J.L., Lee J.E., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15 (1997) 928-937
39. Breslin T.M., Hess K.R., Harbison D.B., et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration. Ann Surg Oncol 8 (2001) 123-132